期刊文献+

过氧化物酶增殖体激活受体β对急性肺损伤大鼠肺组织细胞凋亡的作用机制及影响

Mechanism and effect of peroxisome proliferators-activated receptor-β on acute lung injury in rats with lung tissue apoptosis
下载PDF
导出
摘要 目的探讨过氧化物酶增殖体激活受体β(PPARβ)在急性肺损伤(ALI)发生发展中对肺组织细胞凋亡可能的作用机制,以期从新的视角揭示ALI的发病机理,并为ALI的防治提供新的理论基础。方法参照Cainazzo et al.方法复制失血性休克大鼠ALI模型,测定动脉血氧分压(PaO2)、肺泡灌洗液(BALF)及肺组织细胞凋亡率、计算肺组织湿/干重(W/D)值、病理形态学检查。采用PPARβ的激动剂对大鼠ALI模型进行干预,观察其对失血性休克ALI大鼠的BALF细胞和肺组织细胞凋亡的影响。结果应用PPARβ的激动剂后大鼠的PaO2较对照组显著升高(P<0.05),BALF及肺组织细胞凋亡率、W/D值、肺组织病理学积分均较对照组显著降低(P<0.05)。结论 PPARβ的激动剂对ALI肺组织有一定程度的保护作用,其作用机制是通过抑制炎症反应,减少炎性介质分泌,促进炎症细胞凋亡及减少肺组织细胞凋亡实现的。 Objective To explore the mechanism and effect of peroxisome proliferators-activated receptor-β( PPAR-β) on acute lung injury ( ALI) in rats with lung tissue apoptosis. Methods The arterial blood oxygen par-tial pressure (PaO2) and BALF were detected, the rate of lung tissue apoptosis and lung wet/dry weight (W/D) were calculated. Their pathological morphology was checked. It used PPAR-β activator to intervene on ALI in rat model. ALI uncontrolled hemorrhagic shock and BALF cell apoptosis of lung tissue were observed. Results The lev-el of PaO2 was obviously higher in the study group than in the control group (P&lt;0. 05), and the decrease of BALF, lung tissue apoptosis rate, W/D value and lung tissue pathology score was more pronounced in the study group than in the control group (P〈0. 05). Conclusion PPAR-βagonists has a certain degree of protection for ALI lung tissue, which mechanism of action is by inhibiting the inflammatory reaction and reducing the secretion of inflammatory medi-ators.
出处 《临床肺科杂志》 2014年第9期1556-1559,共4页 Journal of Clinical Pulmonary Medicine
基金 辽宁省自然科学基金(201202243)
关键词 急性肺损伤 过氧化物酶增殖体激活受体 炎症 细胞凋亡 acute lung injury peroxisome proliferators-activated receptor inflammation cell apoptosis
  • 相关文献

参考文献12

  • 1徐鹏,张骅,李树生.糖皮质激素在急性肺损伤中的作用[J].临床肺科杂志,2008,13(10):1310-1312. 被引量:5
  • 2Galani V, Tatsaki E, Bai M, et al. The role of apoptosis in the pathophysiology of acute respiratory distress syndrome (ARDS) :an up-to-date cell-specific review [ J ]. Pathol Res Pract, 2010,206 (3) :145 - 150.
  • 3Jove M, Laguna J C, Vazquez Can'era M. Agonist iAueed activa- tion releases peroxisome proliferator activated receptor β/δ from its inhibition by paCitate iAuced nuclear factor-κB in skeletal muscle cells[ J ]. Biochim BiophysActa, 2005,1734 ( 1 ) : 52 - 61.
  • 4D. Bishop-Baileya A J. Bystrom. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation, [ J ]. Pharmaeol Ther, 2009,124 : 141 - 150.
  • 5Kapoor A, Shintani Y, Collino M, et al. Protective role of peroxi- some proliferator-activated receptor-beta/delta in septic shock[ J].Am J Respir Crit Care Med,2010,182(16) :1506 -1515.
  • 6Vamecq J, Latruffe N. Medical significance of peroxisome prolifera- tors-activated receptors [ J ]. Lancet, 1999, 354 (9173) : 141 - 148.
  • 7Kilgore KS, Billin AN.. PPAR β/δ ligands as modulators of the inflammatory response. [ J ]. Curr Opin Investig Drugs, 2008,9 (5) :463 - 469.
  • 8Piqueras L, Sanz MJ, Perretti M,. Activation of PPAR β/δ inhib- its leukocyte recruitment, cell adhesion molecule expression, and chemokine release. [ J ]. Leukoc Biol,2009,86 ( 1 ) : 115 - 122.
  • 9Haskova Z, Hoang B, Luo G, et al. Modulation of LPS-induced pul- monary neutrophil infiltration and cytokine production by the selec- tive PPAR β/δ ligand GW0742 [ J ]. Inflamm Res, 2008,57 (7) : 314 -21.
  • 10蒋海露,尹凯,唐朝克.过氧化物酶体增殖物激活受体与炎症性疾病[J].生命的化学,2009,29(5):727-730. 被引量:5

二级参考文献45

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部